Silverfin false 31/03/2023 01/04/2022 31/03/2023 M M Whyte 05/03/2019 23 October 2023 The principal activity of the company during the financial year was the sale of chemical products. 11860486 2023-03-31 11860486 bus:Director1 2023-03-31 11860486 2022-03-31 11860486 core:CurrentFinancialInstruments 2023-03-31 11860486 core:CurrentFinancialInstruments 2022-03-31 11860486 core:Non-currentFinancialInstruments 2023-03-31 11860486 core:Non-currentFinancialInstruments 2022-03-31 11860486 core:ShareCapital 2023-03-31 11860486 core:ShareCapital 2022-03-31 11860486 core:RetainedEarningsAccumulatedLosses 2023-03-31 11860486 core:RetainedEarningsAccumulatedLosses 2022-03-31 11860486 core:OtherPropertyPlantEquipment 2022-03-31 11860486 core:OtherPropertyPlantEquipment 2023-03-31 11860486 core:ImmediateParent core:CurrentFinancialInstruments 2023-03-31 11860486 core:ImmediateParent core:CurrentFinancialInstruments 2022-03-31 11860486 bus:OrdinaryShareClass1 2023-03-31 11860486 2022-04-01 2023-03-31 11860486 bus:FullAccounts 2022-04-01 2023-03-31 11860486 bus:SmallEntities 2022-04-01 2023-03-31 11860486 bus:AuditExemptWithAccountantsReport 2022-04-01 2023-03-31 11860486 bus:PrivateLimitedCompanyLtd 2022-04-01 2023-03-31 11860486 bus:Director1 2022-04-01 2023-03-31 11860486 core:OtherPropertyPlantEquipment core:TopRangeValue 2022-04-01 2023-03-31 11860486 2021-04-01 2022-03-31 11860486 core:Non-currentFinancialInstruments 2022-04-01 2023-03-31 11860486 bus:OrdinaryShareClass1 2022-04-01 2023-03-31 11860486 bus:OrdinaryShareClass1 2021-04-01 2022-03-31 iso4217:GBP xbrli:pure xbrli:shares

Company No: 11860486 (England and Wales)

LILY CHEMICALS LIMITED

Unaudited Financial Statements
For the financial year ended 31 March 2023
Pages for filing with the registrar

LILY CHEMICALS LIMITED

Unaudited Financial Statements

For the financial year ended 31 March 2023

Contents

LILY CHEMICALS LIMITED

STATEMENT OF FINANCIAL POSITION

As at 31 March 2023
LILY CHEMICALS LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 31 March 2023
Note 2023 2022
£ £
Current assets
Stocks 4 384,307 785,426
Debtors 5 274,624 430,370
Cash at bank and in hand 6 689,357 246,142
1,348,288 1,461,938
Creditors: amounts falling due within one year 7 ( 1,096,848) ( 1,325,555)
Net current assets 251,440 136,383
Total assets less current liabilities 251,440 136,383
Creditors: amounts falling due after more than one year 8 ( 31,569) ( 41,193)
Net assets 219,871 95,190
Capital and reserves
Called-up share capital 9 1 1
Profit and loss account 219,870 95,189
Total shareholder's funds 219,871 95,190

For the financial year ending 31 March 2023 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Lily Chemicals Limited (registered number: 11860486) were approved and authorised for issue by the Director. They were signed on its behalf by:

M M Whyte
Director

23 October 2023

LILY CHEMICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
LILY CHEMICALS LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 March 2023
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Lily Chemicals Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Office 9, Dalton House, 60 Windsor Avenue, London, SW19 2RR, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Plant and machinery etc. 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Non-financial assets
At each balance sheet date, the company reviews its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss.

If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Financial instruments

The Company only enters into basic financial instruments and transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and loans from related parties.

Financial assets
Basic financial assets, including trade and other debtors, and amounts due from related companies, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Such assets are subsequently carried at amortised cost using the effective interest method.

At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the Statement of Income and Retained Earnings.

Financial liabilities
Basic financial liabilities, including trade and other creditors and accruals, are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Financial liabilities are derecognised when the liability is extinguished, that is when the contractual obligation is discharged, cancelled or expires.

Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Statement of Financial Position date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

2. Employees

2023 2022
Number Number
Monthly average number of persons employed by the Company during the year, including the director 2 2

3. Tangible assets

Plant and machinery etc. Total
£ £
Cost
At 01 April 2022 420 420
At 31 March 2023 420 420
Accumulated depreciation
At 01 April 2022 420 420
At 31 March 2023 420 420
Net book value
At 31 March 2023 0 0
At 31 March 2022 0 0

4. Stocks

2023 2022
£ £
Stocks 384,307 785,426

5. Debtors

2023 2022
£ £
Trade debtors 261,648 421,665
Corporation tax 0 1,014
Other debtors 12,976 7,691
274,624 430,370

6. Cash and cash equivalents

2023 2022
£ £
Cash at bank and in hand 664,507 226,892
Short-term deposits 24,850 19,250
689,357 246,142

7. Creditors: amounts falling due within one year

2023 2022
£ £
Bank loans 9,724 8,706
Trade creditors 48,919 224,021
Amounts owed to Parent undertakings 182,500 200,139
Taxation and social security 213,123 155,876
Other creditors 642,582 736,813
1,096,848 1,325,555

8. Creditors: amounts falling due after more than one year

2023 2022
£ £
Bank loans 31,569 41,193

There are no amounts included above in respect of which any security has been given by the small entity.

9. Called-up share capital

2023 2022
£ £
Allotted, called-up and fully-paid
1 Ordinary share of £ 1.00 1 1

10. Related party transactions

Transactions with owners holding a participating interest in the entity

2023 2022
£ £
Included in creditors is a balance owed to the parent company. This balance is unsecured and interest free with no fixed repayment terms. 182,500 200,139

Transactions with the entity's director

2023 2022
£ £
Included in other creditors is a balance which is owed to the director. This balance is unsecured and interest free with no fixed repayment terms. 631,185 733,239

11. Ultimate controlling party

Parent Company:

Yalepoint Limited
15 Dollis Avenue, London, England, N3 1UD